GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Miami, Florida. The Company’s products include Intelligent Control Automation System (ICAS), Encrypted Control Device (ECD), and Variable Base Encryption Compression (VBEC). ICAS integrates control, telemetry, video, and communications in a seamless interface designed to control complex processes with limited human resources. ICAS offers customized automation solutions that align with the specific requirements of industrial processes without disrupting their current operations. ECD is a multi-platform input/output solution designed to maintain secure control management. VBEC is an efficient compression protocol to enable transmission of AES-256 encryption blocks fragmented into smaller length packets compatible with existing 2.4 GHz airwaves. The firm's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security.

Industry: Pharmaceutical Preparations Peers: Kaya Holdings Inc Baudax Bio, Inc. Bespoke Extracts Inc Clarus Therapeutics Holdings, Inc. Earth Science Tech Inc Innovation1 Biotech Inc. Johnson & Johnson NEUROPATHIX, INC.